Whole-Brain Atrophy Rate in Idiopathic Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy

In multiple system atrophy (MSA) and progressive supranuclear palsy (PSP), the absence of surrogate endpoints makes clinical trials long and expensive. We aim to determine annualized whole-brain atrophy rates (a-WBAR) in idiopathic Parkinson's disease (IPD), MSA, and PSP. Ten healthy controls,...

Descripción completa

Detalles Bibliográficos
Autores principales: Guevara, C., Bulatova, K., Barker, G. J., Gonzalez, G., Crossley, N., Kempton, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848442/
https://www.ncbi.nlm.nih.gov/pubmed/27190673
http://dx.doi.org/10.1155/2016/9631041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848442/
https://www.ncbi.nlm.nih.gov/pubmed/27190673
http://dx.doi.org/10.1155/2016/9631041

Ejemplares similares